NEPHROCARE — Nephro Care India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.37bn
- IN₹1.20bn
- IN₹887.35m
Annual cashflow statement for Nephro Care India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.002 | 25.8 | 62.2 | 48.3 | 46.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.137 | 0.071 | -2.68 | -11.6 | -3.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.92 | 7.53 | -55.7 | 14 | -71.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6.17 | 41.2 | 9.11 | 78.2 | 22.1 |
| Capital Expenditures | -28.9 | -5.05 | -32.9 | -298 | -78.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.819 | -18.3 | -42.5 | -97.5 | 73.7 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -28.1 | -23.3 | -75.4 | -396 | -4.32 |
| Financing Cash Flow Items | -0.147 | -0.08 | 79.9 | 305 | 0.49 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.2 | -0.815 | 56 | 351 | 0.49 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.27 | 17.1 | -10.3 | 33.7 | 18.3 |